Abstract
NEUROLEPTIC drugs are thought to act by blocking brain dopamine receptors1. In vitro binding assays using either 3H-haloperidol2,3 or 3H-spiperone4,5 have provided more direct evidence of this interaction. Although spiperone has been reported to label serotonergic receptors in the frontal cortex6, in the rat striatum, in both in vitro4–9 and in vivo conditions5,10,11, the binding characteristics of this drug are dopaminergic. Initial attempts to solubilise the neuroleptic receptor were recently undertaken in our laboratory, but the 3H-spiperone macromolecular complex obtained from rat striatal membranes after digitonin treatment12 did not show the original highaffinity binding characteristics for dopamine agonists and antagonists except for spiperone itself. More recently, solubilised neuroleptic sites were found in digitonin extracts from calf caudate but they were still not characterised13. We now report the solubilisation of binding sites from dog striatum which retain the characteristics of membrane-bound dopamine receptors.
Similar content being viewed by others
References
Iversen, L. L. Science 188, 1084–1089 (1975).
Seeman, P., Chau-Wong, M., Tedesco, J. & Wong, K. Proc. natn. Acad. Sci. U.S.A. 72, 4376–4380 (1975).
Creese, I., Burt, D. R. & Snyder, S. H. Life Sci. 17, 993–1002 (1975).
Leysen, J. E., Gommeren, W. & Laduron, P. M. Biochem. Pharmac. 27, 307–316 (1978).
Laduron, P. M., Janssen, P. F. M. & Leysen, J. E. Biochem. Pharmac. 27, 317–321 (1978).
Leysen, J. E., Niemegeers, C. J. E., Tollenaere, J. P. & Laduron, P. M. Nature 272, 168–171 (1978).
Fields, J. Z., Reisine, T. D. & Yamamura, H. I. Brain Res. 136, 578–584 (1977).
Howlett, D. R. & Nahorski, S. R. FEBS Lett. 87, 152–156 (1978).
Quik, M., Iversen, L. L., Larder, A. & Mackay, A. V. P. Nature 274, 513–514 (1978).
Laduron, P. & Leysen, J. Biochem. Pharmac. 26, 1003–1007 (1977).
Kuhar, M. J., Murrin, L. C., Malouf, A. T. & Klemn, N. Life Sci. 22, 203–210 (1978).
Gorissen, H. & Laduron, P. M. Life Sci. 23, 575–580 (1978).
Tam, S. & Seeman, P. Eur. J. Pharmac. 52, 151–152 (1978).
Gorissen, H., Aerts, G. & Laduron, P. FEBS Lett. 96, 64–68 (1978).
Gorissen, H., Aerts, G. & Laduron, P. FEBS Lett. (in the press).
Horowski, R. & Wachtel, H. Eur. J. Pharmac. 36, 373–383 (1976).
Seeman, P. Biochem. Pharmac. 26, 1741–1748 (1977).
Frisk-Holmberg, M. & van der Kleijn, E. Eur. J. Pharmac. 18, 139–147 (1972).
Phillips, E. & Livingston, A. Gen. Pharmac. 7, 293–298 (1976).
Leysen, J., Tollenaere, J. P., Koch, M. H. J. & Laduron, P. Eur. J. Pharmac. 43, 253–267 (1977).
Leysen, J. E. & Gommeren, W. Life Sci. 23, 447–452 (1978).
Janssen, P. A. J., Niemegeers, C. J. E. & Schellekens, K. H. L. Arzneim.-Forsch. 15, 1196–1206 (1965).
Niemegeers, C. J. E. & Janssen, P. A. J. Life Sci. (in the press).
Helenius, A. & Simons, K. Biochim. biophys. Acta 415, 29–79 (1975).
Cannon, J. G., Costall, B., Laduron, P. M., Leysen, J. E. & Naylor, R. J. Biochem. Pharmac. 27, 1417–1420 (1978).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
GORISSEN, H., LADURON, P. Solubilisation of high-affinity dopamine receptors. Nature 279, 72–74 (1979). https://doi.org/10.1038/279072a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/279072a0
- Springer Nature Limited
This article is cited by
-
Dopamine mediates vagal modulation of the immune system by electroacupuncture
Nature Medicine (2014)
-
Molecular aspects of the imipramine ‘receptor’
Experientia (1984)